Status:
RECRUITING
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
Lead Sponsor:
University of Chicago
Conditions:
Liver Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in p...
Detailed Description
Prospective study of patients seen at the Univ. of Chicago Medical Center hospital and ambulatory clinics. The assessment of the MAsS score will require an additional 8-10 minutes in the MRI for each ...
Eligibility Criteria
Inclusion
- Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated
Exclusion
- \<18 yrs. of age
Key Trial Info
Start Date :
April 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05264051
Start Date
April 18 2022
End Date
March 1 2027
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago
Chicago, Illinois, United States, 60637